337 related articles for article (PubMed ID: 18940011)
21. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide gene expression profiles of thyroid carcinoma: Identification of molecular targets for treatment of thyroid carcinoma.
Nikolova DN; Zembutsu H; Sechanov T; Vidinov K; Kee LS; Ivanova R; Becheva E; Kocova M; Toncheva D; Nakamura Y
Oncol Rep; 2008 Jul; 20(1):105-21. PubMed ID: 18575725
[TBL] [Abstract][Full Text] [Related]
23. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
Yang Y
Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):304-6, 22. PubMed ID: 1667490
[TBL] [Abstract][Full Text] [Related]
24. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.
van Staveren WC; Solís DW; Delys L; Venet D; Cappello M; Andry G; Dumont JE; Libert F; Detours V; Maenhaut C
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):413-8. PubMed ID: 16381821
[TBL] [Abstract][Full Text] [Related]
25. Expression and prognostic value of NDRG2 in human astrocytomas.
Li L; Wang J; Shen X; Wang L; Li X; Liu Y; Shi M; Zhao G; Deng Y
J Neurol Sci; 2011 Sep; 308(1-2):77-82. PubMed ID: 21705028
[TBL] [Abstract][Full Text] [Related]
26. Expression analysis of the NDRG2 gene in mouse embryonic and adult tissues.
Hu XL; Liu XP; Deng YC; Lin SX; Wu L; Zhang J; Wang LF; Wang XB; Li X; Shen L; Zhang YQ; Yao LB
Cell Tissue Res; 2006 Jul; 325(1):67-76. PubMed ID: 16520977
[TBL] [Abstract][Full Text] [Related]
27. Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death.
Choi SC; Yoon SR; Park YP; Song EY; Kim JW; Kim WH; Yang Y; Lim JS; Lee HG
Exp Mol Med; 2007 Dec; 39(6):705-14. PubMed ID: 18160841
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature.
Wada N; Yoshida A; Miyagi Y; Yamamoto T; Nakayama H; Suganuma N; Matsuzu K; Masudo K; Hirakawa S; Rino Y; Masuda M; Imada T
Anticancer Res; 2008; 28(1A):139-44. PubMed ID: 18383837
[TBL] [Abstract][Full Text] [Related]
29. Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma.
Tseleni-Balafouta S; Gakiopoulou H; Fanourakis G; Voutsinas G; Balafoutas D; Patsouris E
Exp Mol Pathol; 2006 Apr; 80(2):177-82. PubMed ID: 16259977
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
[TBL] [Abstract][Full Text] [Related]
31. Localization of N-myc downstream-regulated gene 1 in gastric cancer tissue.
Inagaki Y; Tang W; Xu HL; Guo Q; Mafune K; Konishi T; Nakata M; Sugawara Y; Kokudo N
Dig Liver Dis; 2009 Feb; 41(2):96-103. PubMed ID: 18602353
[TBL] [Abstract][Full Text] [Related]
32. Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene.
Gao L; Wu GJ; Liu XW; Zhang R; Yu L; Zhang G; Liu F; Yu CG; Yuan JL; Wang H; Yao LB
Cancer Lett; 2011 Nov; 310(1):94-100. PubMed ID: 21741166
[TBL] [Abstract][Full Text] [Related]
33. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
34. [Expression and structure of BNIP3L in lung cancer].
Sun JL; He XS; Yu YH; Chen ZC
Ai Zheng; 2004 Jan; 23(1):8-14. PubMed ID: 14720367
[TBL] [Abstract][Full Text] [Related]
35. [Alteration of early growth response 1 expression in gastroenterological cancers and its biological significance].
An J; Guo RF; Zhang L; Geng PL; Lü YY
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1384-9. PubMed ID: 18953875
[TBL] [Abstract][Full Text] [Related]
36. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
37. Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma.
Takano T; Matsuzuka F; Sumizaki H; Kuma K; Amino N
Cancer Res; 1997 Sep; 57(17):3792-7. PubMed ID: 9288789
[TBL] [Abstract][Full Text] [Related]
38. The physical and functional interaction of NDRG2 with MSP58 in cells.
Zhang J; Liu J; Li X; Li F; Wang L; Zhang J; Liu X; Shen L; Liu N; Deng Y; Yang A; Han H; Zhao M; Yao L
Biochem Biophys Res Commun; 2007 Jan; 352(1):6-11. PubMed ID: 17109818
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid receptor subunit gene expression in thyroid gland and adenomas.
Zhang XW; Li Y; Wang ZL; Li P
Acta Oncol; 2006; 45(8):1073-8. PubMed ID: 17118842
[TBL] [Abstract][Full Text] [Related]
40. Differential CXC receptor expression in colorectal carcinomas.
Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
